Hims & Hers Health HIMS Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 73.8%-5.6pp | 79.5%-2.5pp | 82%+4.4pp | 77.6%+2.4pp | |
| Operating margin | 4.5%+0.3pp | 4.2%+7.6pp | -3.4%+9.7pp | -13%+29.3pp | |
| Net margin | 5.5%-3.1pp | 8.5%+11.4pp | -2.8%+9.6pp | -12.5%+27.1pp | |
| Returns | |||||
| Return on equity | 25.2%-5.5pp | 30.7%+38.3pp | -7.6%+12.8pp | -20.3%— | |
| Return on invested capital | 29.1%+5.4pp | 23.7%+34.9pp | -11.2%+14.4pp | -25.6%— | |
| Efficiency | |||||
| Asset turnover | 1.6×-0.9× | 2.6×+0.4× | 2.2×+0.8× | 1.3×+0.3× | |
| Liquidity | |||||
| Current ratio | 1.9×+0.1× | 1.8×-1.2× | 3×-1.5× | 4.5×+1.1× | |
| Leverage | |||||
| Debt-to-equity | 0.3×+0.2× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -0.5×+2.2× | -2.7×— | —— | —— | |
| Per Share | |||||
| Book value per share | $2.09+4.1% | $2.01+22.5% | $1.64+7.8% | $1.52-14.9% | |
| Valuation | |||||
| Market capitalization | $7.39B+39.9% | $5.28B+181% | $1.88B+42.5% | $1.32B-0.5% | |
| Price / earnings | 57.6×+15.7× | 41.9×— | —— | —— | |
| Price / sales | 3.1×-0.4× | 3.6×+1.4× | 2.2×-0.3× | 2.5×-2.4× | |
| Price / book | 13.7×+2.6× | 11.1×+5.6× | 5.5×+1.2× | 4.2×+0.3× | |
| EV / EBITDA | 45.7×-18.6× | 64.2×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Hims & Hers Health's profit margins?
- Hims & Hers Health (HIMS) runs a 71.7% gross margin and a -1.3% operating margin, with a -0.6% net margin.
- Where do Hims & Hers Health's ratios come from?
- Every ratio is computed from Hims & Hers Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
